KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Gross Margin: 2015-2025

Historic Gross Margin for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 86.09%.

  • BeOne Medicines' Gross Margin rose 310.00% to 86.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 86.19%, marking a year-over-year increase of 245.00%. This contributed to the annual value of 84.41% for FY2024, which is 14.00% down from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Gross Margin is 86.09%, which was down 1.60% from 87.49% recorded in Q2 2025.
  • BeOne Medicines' 5-year Gross Margin high stood at 94.61% for Q1 2021, and its period low was 75.82% during Q2 2021.
  • For the 3-year period, BeOne Medicines' Gross Margin averaged around 84.79%, with its median value being 85.13% (2024).
  • Per our database at Business Quant, BeOne Medicines' Gross Margin skyrocketed by 2,178bps in 2021 and then plummeted by 1,588bps in 2022.
  • BeOne Medicines' Gross Margin (Quarterly) stood at 77.31% in 2021, then soared by 334bps to 80.66% in 2022, then spiked by 266bps to 83.32% in 2023, then surged by 245bps to 85.76% in 2024, then soared by 310bps to 86.09% in 2025.
  • Its Gross Margin was 86.09% in Q3 2025, compared to 87.49% in Q2 2025 and 85.23% in Q1 2025.